Portal de investigação
Biologicals in severe chronic rhinosinusitis with nasal polyps: translation to clinical practice while waiting for head-to-head studies
Autores da FMUP
Participantes de fora da FMUP
- Boechat, JL
Unidades de investigação
Abstract
<jats:p>Dear Editor: Chronic rhinosinusitis with nasal polyps (CRSwNP) affects 1.0-2.6% of the population (1) and results in relevant direct and indirect costs. Recently, several randomized controlled trials (RCTs) with Type 2-targeting biologicals (anti-IL4R?, anti-IL5R, anti-IL5 and anti-IgE) opened a new treatment field for patients refractory to first-line treatments (2,3).</jats:p>
Dados da publicação
- ISSN/ISSNe:
- 0300-0729,
- Tipo:
- Letter
- Páginas:
- 283-283
- DOI:
- 10.4193/Rhin22.436
- Link para outro recurso:
- www.scopus.com
Rhinology University Hospital Utrecht
Citações Recebidas na Scopus: 6
Documentos
- Não há documentos
Filiações
Keywords
- Biological Products; Chronic Disease; Humans; Nasal Polyps; Rhinitis; Sinusitis; biological product; chronic disease; human; nose polyp; rhinitis; sinusitis
Proyectos asociados
Molecular Allergen Based Diagnosis Impact on Clinical Efficacy of Aeroallergen Immunotherapy- a Pragmatic Randomized Clinical Trial (CRD-AIT) - NCT05448066
Investigador Principal: Diana Margarida Gonçalves Solha Pereira da Silva
Ensaio Clínico Académico (CRD-AIT) . SP Alergologia Imunologia Clinica . 2022
Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers
Investigador Principal: Bernardo Manuel De Sousa Pinto
Estudo Clínico Académico (SARS-CoV-2) . 2021
Citar a publicação
Boechat JL,Sousa B,Delgado L,Silva D. Biologicals in severe chronic rhinosinusitis with nasal polyps: translation to clinical practice while waiting for head-to-head studies. Rhinology. 2023. 61(3):p. 283-283. IF:7,200. (1).
